Items where Division is "Clinical Research" and Year is 2023

Bhaskar, A and Ramraj, B and Padmapriyadarsini, C and Reddy, D (2023) QTc prolongation with bedaquiline treatment for drug-resistant pulmonary TB in a programmatic setting. QTc prolongation with bedaquiline treatment for drug-resistant pulmonary TB in a programmatic setting., 27(4) (329-31).

Bhavani, PK and Padmapriyadarshini, C and Padmapriyadarsini, C and Reddy, D (2023) The First Differentiated TB Care Model From India: Delays and Predictors of Losses in the Care Cascade. The First Differentiated TB Care Model From India: Delays and Predictors of Losses in the Care Cascade, 11(2) (e22005).

Chandrasekaran, P. and Thiruvengadam, K. and Shivakumar, SVBY and Hanna, L E (2023) Characterising cause of death among people treated for drug-susceptible TB in India. Characterising cause of death among people treated for drug-susceptible TB in India, 27(1) (78-80).

Daniel, Bella Devaleenal and Baskaran, A and Baskaran, Dhanaraj and Mercy, H (2023) Addressing the challenges in implementing airborne infection control guidelines and embracing the policies. Indian Journal of Tuberculosis. ISSN Electronic: 0019-5707

Devaleenal, DB and Thiruvengadam, K. and Giridharan, P and Velayudham, B and Krishnan, R and Dhanaraj, B and Chandrasekaran, P and Babu, S (2023) Holistic Approach to Enhance Airborne Infection Control Practices in Health Care Facilities Involved in the Management of Tuberculosis in a Metropolitan City in India – An Implementation Research. Holistic Approach to Enhance Airborne Infection Control Practices in Health Care Facilities Involved in the Management of Tuberculosis in a Metropolitan City in India – An Implementation Research, 12(1) (38-44).

Inbaraj, LR (2023) Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves. Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves, 12 (129802).

Inbaraj, LR (2023) Effectiveness of Adjunctive High-Dose Infliximab Therapy to Improve Disability-Free Survival Among Patients With Severe Central Nervous System Tuberculosis: A Matched Retrospective Cohort Study. Effectiveness of Adjunctive High-Dose Infliximab Therapy to Improve Disability-Free Survival Among Patients With Severe Central Nervous System Tuberculosis: A Matched Retrospective Cohort Study, 77(10) (146067).

Inbaraj, LR and Srinivasalu, VA and Padmapriyadarsini, C (2023) Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review. Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review, 10 (108501).

Inbaraj, Leeberk Raja and Daniel, Jefferson and Rajendran, Priya and Bhaskar, Adhin and Srinivasalu, Vignes Anand and Narayanan, Mukesh KS and Shewade, Hemant D and Kirubakaran, Richard and Scandrett, Katie and Malaisamy, Muniyandi and Takwoingi, Yemisi and Padmapriyadarsini, Chandrasekaran (2023) Truenat MTB assays for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews, 2023 (1). ISSN 14651858

Leeberk Raja, Inbaraj (2023) Analysis of intrathecal clonidine as an adjuvant in the subarachnoid block on post‑operative analgesia and safety profile in obstetric surgeries: A randomised controlled trial. Analysis of intrathecal clonidine as an adjuvant in the subarachnoid block on post‑operative analgesia and safety profile in obstetric surgeries: A randomised controlled trial, 12(1) (28-34).

Pachauri, Saroj and Pachauri, Ash and Chatterjee, Anirban and Ramraj, Balaji (2023) Global Perspectives of COVID-19 Pandemic on Health, Education, and Role of Media. [error in script], New York. ISBN 978-981-99-1106-6 (eBook)

Padmapriyadarsini, C and Jeyakumar, SM and Muthuvijaylaksmi, M and Reddy, D (2023) Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis. Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis, 12(4) (714).

Perumal Kannabiran, Bhavani and Prathiksha, G and Dhanaraj, Baskaran and Gomathi, N S and Mythily, V and Hemanth Kumar, A K and Silambu Chelvi, K and Sekar, L and Luke Hanna, LE and Ramesh, K (2023) Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV. Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV, 42(10) (899-04).

Velayutham, B and Jayabal, L and Watson, B and Jagadeesan, S and Suresh, C and Nair, D and Gopalaswamy, R and Devaleenal, B and Selvaraju, S and Padmapriyadarsini, C (2023) Status of Universal Drug Susceptibility Testing in Pulmonary Tuberculosis Patients Initiated on Treatment in an Urban Setting, South India. Status of Universal Drug Susceptibility Testing in Pulmonary Tuberculosis Patients Initiated on Treatment in an Urban Setting, South India, 48(1) (103-07).

Velayutham, B and Thiruvengadam, K and Kumaran, P P and Watson, B and Rajendran, K and Padmapriyadarsini, C (2023) Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease. Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease, 2&3 (152-59).

Venkataraman, A (2023) Pediatric COVID-19 and MIS-C – Lessons Learnt and the Way Forward. Pediatric COVID-19 and MIS-C – Lessons Learnt and the Way Forward, 60(5) (347-49).